138 related articles for article (PubMed ID: 14985588)
1. The case of the disappearing nitrosamines: a potentially global phenomenon.
Gray N; Boyle P
Tob Control; 2004 Mar; 13(1):13-6. PubMed ID: 14985588
[TBL] [Abstract][Full Text] [Related]
2. The changing cigarette, 1950-1995.
Hoffmann D; Hoffmann I
J Toxicol Environ Health; 1997 Mar; 50(4):307-64. PubMed ID: 9120872
[TBL] [Abstract][Full Text] [Related]
3. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
[TBL] [Abstract][Full Text] [Related]
4. Determination of carcinogenic tobacco-specific nitrosamines in mainstream smoke from U.S.-brand and non-U.S.-brand cigarettes from 14 countries.
Wu W; Zhang L; Jain RB; Ashley DL; Watson CH
Nicotine Tob Res; 2005 Jun; 7(3):443-51. PubMed ID: 16085512
[TBL] [Abstract][Full Text] [Related]
5. Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties.
Ding YS; Zhang L; Jain RB; Jain N; Wang RY; Ashley DL; Watson CH
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3366-71. PubMed ID: 19064552
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in sidestream cigarette smoke increase after release into indoor air: results from unpublished tobacco industry research.
Schick SF; Glantz S
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1547-53. PubMed ID: 17684127
[TBL] [Abstract][Full Text] [Related]
7. Formation and analysis of tobacco-specific N-nitrosamines.
Brunnemann KD; Prokopczyk B; Djordjevic MV; Hoffmann D
Crit Rev Toxicol; 1996; 26(2):121-37. PubMed ID: 8688156
[TBL] [Abstract][Full Text] [Related]
8. Thirdhand cigarette smoke in an experimental chamber: evidence of surface deposition of nicotine, nitrosamines and polycyclic aromatic hydrocarbons and de novo formation of NNK.
Schick SF; Farraro KF; Perrino C; Sleiman M; van de Vossenberg G; Trinh MP; Hammond SK; Jenkins BM; Balmes J
Tob Control; 2014 Mar; 23(2):152-9. PubMed ID: 23716171
[TBL] [Abstract][Full Text] [Related]
9. Exposure to nitrosamines in thirdhand tobacco smoke increases cancer risk in non-smokers.
Ramírez N; Özel MZ; Lewis AC; Marcé RM; Borrull F; Hamilton JF
Environ Int; 2014 Oct; 71():139-47. PubMed ID: 25036615
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of four tobacco-specific N-nitrosamines in mainstream smoke for Chinese Virginia cigarettes by liquid chromatography-tandem mass spectrometry and validation under ISO and "Canadian intense" machine smoking regimes.
Xiong W; Hou H; Jiang X; Tang G; Hu Q
Anal Chim Acta; 2010 Jul; 674(1):71-8. PubMed ID: 20638502
[TBL] [Abstract][Full Text] [Related]
11. Addition of porphyrins to cigarette filters to reduce the levels of benzo[a]pyrene (B[a]P) and tobacco-specific N-nitrosamines (TSNAs) in mainstream cigarette smoke.
Wang C; Dai Y; Feng G; He R; Yang W; Li D; Zhou X; Zhu L; Tan L
J Agric Food Chem; 2011 Jul; 59(13):7172-7. PubMed ID: 21662235
[TBL] [Abstract][Full Text] [Related]
12. Smoke yields of tobacco-specific nitrosamines in relation to FTC tar level and cigarette manufacturer: analysis of the Massachusetts Benchmark Study.
Harris JE
Public Health Rep; 2001; 116(4):336-43. PubMed ID: 12037262
[TBL] [Abstract][Full Text] [Related]
13. TSNA levels in machine-generated mainstream cigarette smoke: 35 years of data.
Appleton S; Olegario RM; Lipowicz PJ
Regul Toxicol Pharmacol; 2013 Jul; 66(2):197-207. PubMed ID: 23557986
[TBL] [Abstract][Full Text] [Related]
14. Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure.
Fischer S; Spiegelhalder B; Preussmann R
IARC Sci Publ; 1991; (105):489-92. PubMed ID: 1855903
[TBL] [Abstract][Full Text] [Related]
15. The development of scientific consultants: how the tobacco industry creates controversy on the carcinogenicity of tobacco-specific nitrosamines.
Kyriss T; Schneider NK
Tob Control; 2013 May; 22(3):e3. PubMed ID: 22940678
[TBL] [Abstract][Full Text] [Related]
16. Chemical constituents and bioactivity of tobacco smoke.
Hoffmann D; Wynder EL
IARC Sci Publ; 1986; (74):145-65. PubMed ID: 3623665
[TBL] [Abstract][Full Text] [Related]
17. Assessment of tobacco-specific nitrosamines in the tobacco and mainstream smoke of Bidi cigarettes.
Wu W; Song S; Ashley DL; Watson CH
Carcinogenesis; 2004 Feb; 25(2):283-7. PubMed ID: 14604898
[TBL] [Abstract][Full Text] [Related]
18. Tobacco-specific nitrosamines: A literature review.
Konstantinou E; Fotopoulou F; Drosos A; Dimakopoulou N; Zagoriti Z; Niarchos A; Makrynioti D; Kouretas D; Farsalinos K; Lagoumintzis G; Poulas K
Food Chem Toxicol; 2018 Aug; 118():198-203. PubMed ID: 29751076
[TBL] [Abstract][Full Text] [Related]
19. Chemical studies on tobacco smoke LVI. Tobacco specific nitrosamines: origins, carcinogenicity and metabolism.
Hecht SS; Chen CB; Ornaf RM; Hoffmann D; Tso TC
IARC Sci Publ (1971); 1978; (19):395-413. PubMed ID: 680735
[TBL] [Abstract][Full Text] [Related]
20. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines.
Stanfill SB; Connolly GN; Zhang L; Jia LT; Henningfield JE; Richter P; Lawler TS; Ayo-Yusuf OA; Ashley DL; Watson CH
Tob Control; 2011 May; 20(3):e2. PubMed ID: 21109685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
